Eltrombopag Cholin 50 Mg Tablet Suppliers & Bulk Manufacturers

Available Forms: Tablets / Oral suspension

Available Strengths: 12.5 mg, 25 mg, 50 mg, and 75 mg

Reference Brands: Promacta (USA), Revolade (EU)

Category: Anemia

Product Description:

Eltrombopag, marketed under the brand names Promacta in the USA and Revolade in other countries, is an oral medication used to treat thrombocytopenia and severe aplastic anemia. It belongs to the class of thrombopoietin receptor agonists, which work by stimulating the thrombopoietin receptor on bone marrow cells, thereby promoting the production of platelets. This mechanism helps patients with abnormally low platelet counts to achieve safer levels, reducing the risk of bleeding complications.

Eltrombopag is commonly prescribed for conditions such as chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia associated with chronic hepatitis C infection. It is administered orally and is typically taken once daily, with dosing adjusted according to platelet counts and individual patient response.

Originally discovered through a research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals, eltrombopag development and marketing rights were later transferred to Novartis Pharmaceuticals. The medication has become an essential therapy for patients with platelet deficiencies, offering a non-invasive alternative to platelet transfusions and improving quality of life for individuals with chronic hematologic conditions.